The dual effect of prostaglandin (PGE2) and ethanol on the natural killer cytolytic process: effector activation and NK-cell-target cell conjugate lytic inhibition.
Open Access
- 1 December 1980
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 125 (6) , 2770-2777
- https://doi.org/10.4049/jimmunol.125.6.2770
Abstract
R A Kendall, S Targan; The dual effect of prostaglandin (PGE2) and ethanol on the natural killer cytolytic process: effector activation and NK-cell-target cellThis publication has 10 references indexed in Scilit:
- Interferon activation of "pre-spontaneous killer" (pre-SK) cells and alteration in kinetics of lysis of both "pre-SK" and active SK cells.The Journal of Immunology, 1980
- Suppression of Natural Cytotoxicity by Spleen Cells of Hydrocortisone-Treated MiceThe Journal of Immunology, 1979
- Activation of Human Natural Killer Cells Cytotoxic for Human Leukemia Cells by Purified InterferonThe Journal of Immunology, 1979
- CYTOTOXIC CELLS INDUCED DURING LYMPHOCYTIC CHORIOMENINGITIS VIRUS-INFECTION OF MICE .2. SPECIFICITIES OF THE NATURAL KILLER CELLS1979
- TARGET-EFFECTOR INTERACTION IN THE NATURAL KILLER CELL SYSTEM .4. MODULATION BY CYCLIC-NUCLEOTIDES1979
- A possible role of prostaglandins in the inhibition of natural and antibody-dependent cell-mediated cytotoxicity against tumor cellsCellular Immunology, 1978
- Enhancement of natural and antibody-dependent lymphocyte cytotoxicity by drugs which inhibit prostaglandin production by tumor target cellsCellular Immunology, 1978
- In vitro induction of cytotoxic effector cells with spontaneous killer cell specificity.The Journal of Experimental Medicine, 1978
- Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells. Enhancement of human natural killer cell activity by interferon and antagonistic inhibition of susceptibility of target cells to lysis.The Journal of Experimental Medicine, 1978
- Subversion of host defense mechanisms by malignant tumors: an established tumor as a privileged site for bacterial growth.The Journal of Experimental Medicine, 1977